clinical trials

News

US is planning $500m project on 'universal vaccines;' WSJ

The US will spend $500m to develop universal vaccines against multiple virus variants, while planned changes to testing rules are raising concerns.

News

Dr Yu Xia, founder, chairwoman, president and chief executive of Akeso

Akeso PD-1 inhibitor cleared as Keytruda challenger advances

Akeso has bagged an FDA approval for its PD-1 inhibitor penpulimab and reported new data on highly-touted PD-1/VEGF bispecific ivonescimab.

News

Can Bioxodes end the dearth of haemorrhagic stroke drugs?

There is currently no approved treatment for intracerebral haemorrhagic stroke, but Belgian start-up Bioxodes hopes to change that.

R&D

Shifting paradigms of clinical trial design accelerate CNS R...

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed.

News

Has trial result burst BMS' Cobenfy bubble?

Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

News

Data readout puts J&J's bladder cancer drug back on track

New data in non-muscle-invasive bladder cancer (NMIBC) has backed up Johnson & Johnson's faith in its TAR-200 drug candidate.

US is planning $500m project on 'universal vaccines;' WSJ

Akeso PD-1 inhibitor cleared as Keytruda challenger advances

Can Bioxodes end the dearth of haemorrhagic stroke drugs?

Shifting paradigms of clinical trial design accelerate CNS R...

Has trial result burst BMS' Cobenfy bubble?

Data readout puts J&J's bladder cancer drug back on track

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks